3,5-disubstituted-(1,2,4)-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
Details for Australian Patent Application No. 2003303373 (hide)
International Classifications
Event Publications
19 August 2004 Complete Application Filed
Priority application(s): 60/433,953 18.12.02 US
26 August 2004 Application Open to Public Inspection
Published as AU-B-2003303373
11 February 2010 Application Accepted
Published as AU-B-2003303373
10 June 2010 Standard Patent Sealed
10 June 2010 Corrigenda
Applications Accepted - Name Index Under the name Cytovia, Inc., Application No. 2003303373, under INID (54) correct the title to read 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003303374-TREATMENT OF METASTATIC CANCER WITH THE B-SUBUNIT OF SHIGA TOXIN
2003303372-SYSTEM, METHOD AND APPLIANCES FOR APPLYING HAIR TREATMENTS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser